Table 1.
Characteristic, n (%) | Early responders n = 332 | Later responders n = 253 | Patients without Halm-based assessment of TCS n = 1454 |
---|---|---|---|
Age, years, mean (SD) [median] |
63.8 (19.0) [68] |
64.5 (18.2) [69] |
64.7 (18.5) [68] |
≥ 65 years |
187 (55.8) |
137 (54.2) |
827 (56.9) |
Sex, male |
204 (61.4) |
144 (56.9) |
848 (58.3) |
Ethnic origin | |||
White |
225 (67.8) |
217 (85.8) |
1131 (77.8) |
Non-white |
8 (2.4) |
3 (1.2) |
40 (2.8) |
Unknown/missing |
9 (2.7) |
3 (1.2) |
39 (2.7) |
Not applicable* |
90 (27.1) |
30 (11.9) |
244 (16.8) |
Previous admission to hospital with CAP (last 3 months) |
8 (2.4) |
9 (3.6) |
82 (5.6) |
Haemodialysis |
0 |
1 (0.4) |
5 (0.3) |
Chemotherapy for active cancer |
1 (0.3) |
1 (0.4) |
28 (1.9) |
Smoking status† | |||
Non-smoker |
129 (38.5) |
108 (42.7) |
467 (32.1) |
Ex-smoker |
94 (28.1) |
79 (31.2) |
380 (26.1) |
Occasional smoker |
2 (0.6) |
2 (0.8) |
38 (2.6) |
Habitual smoker |
89 (26.8) |
46 (18.2) |
328 (22.6) |
Unknown | 18 (5.4) | 18 (7.1) | 241 (16.6) |
*All patients in this category were from France, where this question is not permitted in clinical studies.
†Definitions: Never smoked: patients who have never smoked > 20 g of tobacco in their lifetime; Ex-smoker: patients who stopped smoking ≥ 365 days ago: Occasional smoker: patients who smoke < 1 tobacco product per day; Habitual smoker: patients who smoke ≥ 1 tobacco products/day.
SD = standard deviation; TCS = time to clinical stability.